This bill requires health insurance plans to provide prostate cancer screenings for high-risk men aged 40 and older without any cost-sharing requirements.
John Boozman
Senator
AR
The PSA Screening for HIM Act mandates that group and individual health insurance plans provide coverage for prostate cancer screenings without cost-sharing for high-risk men aged 40 and older. By removing financial barriers for African-American men and those with a family history of the disease, this legislation aims to improve early detection and survival rates.
Starting January 1, 2025, a new federal mandate will require group and individual health insurance plans to cover prostate cancer screenings with zero cost-sharing for men aged 40 and older who fall into high-risk categories. This means if you meet the criteria, you won't have to pay a co-pay or meet a deductible to get screened. The bill specifically targets African-American men and those with a family history of the disease—groups that clinical data shows are hit hardest and earliest by this specific cancer. By amending the Public Health Service Act, the legislation moves these screenings into the same 'preventive care' bucket as annual physicals or certain immunizations, removing the financial gatekeeping that often delays diagnosis.
The bill is very specific about who qualifies for this $0-deductible screening. Under Section 3, you are considered high-risk if you are African-American or if you have a first-degree relative (like a father or brother) who was diagnosed with, developed, or died from prostate cancer. It also extends this to men whose relatives had other cancers or genetic alterations linked to increased prostate risk. For an office worker in his early 40s who lost an uncle or father to the disease, this change turns a 'maybe next year' medical expense into a standard, free part of his healthcare routine. The goal is to catch the disease while it still has a near 100% survival rate, rather than waiting for symptoms that usually don't show up until the survival rate drops to 37%.
Beyond just the screenings, the Act cleans up some bureaucratic 'fine print' regarding how insurance companies interpret health guidelines. It explicitly tells insurers they cannot use outdated 2009 recommendations to deny coverage and clarifies that while they must cover these high-risk screenings, they are still allowed to offer even broader coverage if they choose. For the self-employed contractor or small business owner paying for their own plan, this provides a clear, legally backed right to preventive care without worrying about a surprise bill in the mail. By investing in these early tests, the bill aims to avoid the hundreds of millions of dollars the healthcare system spends annually on treating advanced, metastatic cancer, effectively trying to save both lives and money by being proactive rather than reactive.